On November 14, ocular physiologist and creative arts benefactor Laszlo Bito passed away from chronic obstructive pulmonary condition, a condition that stemmed from his time as a forced worker in a Hungarian coal mine, according to The New York Times.Bito with his other half Olivia Carino at a book launch in June 2019ANDREA PÓkBito was born in 1934 in Budapest, and in 1951, he and his family were deported from the city by the Hungarian communist routine, according to his websites biographical timeline. He went on to earn his PhD in medical cell biology and biophysics from Columbia University in 1963, according to his website.A July 2000 New York Times post keeps in mind that Bitos research profession focused on prostaglandins (PGs) and their impacts on the fluid that develops up in the eyes of clients with glaucoma. The medicine was patented in 1997 and made both Columbia University and Bito millions of dollars in royalties, according to the Times.
On November 14, ocular physiologist and innovative arts benefactor Laszlo Bito died from persistent obstructive pulmonary condition, a condition that stemmed from his time as a forced worker in a Hungarian coal mine, according to The New York Times.Bito with his better half Olivia Carino at a book launch in June 2019ANDREA PÓkBito was born in 1934 in Budapest, and in 1951, he and his family were deported from the city by the Hungarian communist regime, according to his websites biographical timeline. He ended up in the city of Komlo where we was forced to work in the coal mines. He became a regional leader in a revolt against such required labor, but when the revolution stopped working, he left to Austria. He was approved asylum in the United States in 1956. There, Bito made a degree in chemistry from Bard College in New York. He went on to make his PhD in medical cell biology and biophysics from Columbia University in 1963, according to his website.A July 2000 New York Times short article keeps in mind that Bitos research career focused on prostaglandins (PGs) and their impacts on the fluid that constructs up in the eyes of patients with glaucoma. This fluid can put a lot pressure on the eye that it leads and damages the optic nerve to vision loss. Bito and his colleagues discovered that PGs lower intraocular eye pressure, composing in a 1982 paper that the effect was triggered by “some very standard process typical to all types [tested] Thus we can expect that PGs likewise have a hypotensive result on the human eye.” Indeed, Bitos prostaglandin work caused the advancement of the eyedrop commercially called Xalatan that is recommended for glaucoma clients, according to the drugs distributor Pfizer. The medication was patented in 1997 and made both Columbia University and Bito millions of dollars in royalties, according to the Times. Bito utilized this wealth to money innovative outlets such as radio stations and Bard Colleges conservatory of music. In total, he authored more than 150 clinical research study papers covering elements of eye biology such as the chemical makeup of eye fluids and characteristics of the eye microenvironment, according to the Helen Keller Foundation, which granted him the Helen Keller Prize for Vision Research in 2013. After his retirement from Columbia University in 1998, Bito went on to author numerous books about religion. Bitos better half Olivia Carino tells The New York Times that her other half transitioned from science to theological writing since “He stated he had done enough for physical blindness,” which “Now it was time to do something for spiritual loss of sight.” Bito is endured by Carino and two kids from his first marriage..